{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T19:44:17Z","timestamp":1784403857953,"version":"3.55.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,7,29]],"date-time":"2003-07-29T00:00:00Z","timestamp":1059436800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2003,8]]},"DOI":"10.1038\/sj.bjc.6601127","type":"journal-article","created":{"date-parts":[[2003,7,29]],"date-time":"2003-07-29T17:11:31Z","timestamp":1059498691000},"page":"552-556","source":"Crossref","is-referenced-by-count":289,"title":["Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer"],"prefix":"10.1038","volume":"89","author":[{"given":"J","family":"Edwards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N S","family":"Krishna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K M","family":"Grigor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J M S","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,7,29]]},"reference":[{"key":"BF6601127_CR1","volume-title":"Statistical Methods in Medical Research","author":"P Armitage","year":"1995","unstructured":"Armitage P, Berry G (1995) Statistical Methods in Medical Research, 3 rd ed. Oxford: Blackwell Science"},{"key":"BF6601127_CR2","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0960-0760(00)00158-8","volume":"76","author":"DM Avila","year":"2001","unstructured":"Avila DM, Zoppi S, McPhaul (2001) The androgen receptor in syndromes of insensitivity and prostate cancer. J Steroid Biochem Mol Biol 76: 135\u2013142","journal-title":"J Steroid Biochem Mol Biol"},{"key":"BF6601127_CR3","first-page":"803","volume":"59","author":"L Bubendorf","year":"1999","unstructured":"Bubendorf L, Kononen J, Koivisto P, Schraml P, Moch H, Gasser TC, Willi N, Mihatsch, MJ, Sauter G, Kallioniemi O-P (1999) Survey of gene amplifications during prostate cancer progression by high throughput fluorescence in situ hybridization on tissue microarrays. Cancer Res 59: 803\u2013806","journal-title":"Cancer Res"},{"key":"BF6601127_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/(SICI)1097-0045(19980401)35:1<63::AID-PROS9>3.0.CO;2-I","volume":"35","author":"Z Culig","year":"1998","unstructured":"Culig Z, Hobisch A, Hittmair A, Peterziel H, Cato AC, Bartsch G, Klocker H (1998) Expression, structure, and function of androgen receptor in advanced prostatic carcinoma. Prostate 35: 63\u201370","journal-title":"Prostate"},{"key":"BF6601127_CR5","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1046\/j.1464-410X.2001.02350.x","volume":"88","author":"J Edwards","year":"2001","unstructured":"Edwards J, Krishna NS, Mukherjee R, Watters AD, Underwood MA, Bartlett JMS (2001) Amplification of the androgen receptor may not explain the development of androgen-independent prostate cancer. Br J Urol Int 88: 633\u2013637","journal-title":"Br J Urol Int"},{"key":"BF6601127_CR6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/sj.bjc.6600863","volume":"88","author":"JA Fraser","year":"2003","unstructured":"Fraser JA, Reeves JR, Stanton PD, Black DM, Going JJ, Cooke TG, Bartlett JMS (2003) A role for BRCA1 in sporadic breast cancer. Br J Cancer 88: 1263\u20131270","journal-title":"Br J Cancer"},{"key":"BF6601127_CR7","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1038\/sj.onc.1205663","volume":"21","author":"VJ Gnanapragasam","year":"2002","unstructured":"Gnanapragasam VJ, Robson CN, Neal DE, Leung HY (2002) Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Oncogene 21: 5069\u20135080","journal-title":"Oncogene"},{"key":"BF6601127_CR8","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/sj.pcan.4500323","volume":"2","author":"S Goktas","year":"1999","unstructured":"Goktas S, Ziada A, Crawford ED (1999) Combined androgen blockade for advanced prostatic carcinoma. Prostate Cancer Prostatic Dis 2: 172\u2013179","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"BF6601127_CR9","first-page":"5718","volume":"58","author":"CW Gregory","year":"1998","unstructured":"Gregory CW, Hamil KG, Kim D, Hall SH, Pretlow TG, Mohler JL, French FS (1998) Androgen receptor expression in androgen independent prostate cancer is associated with increased expression of androgen regulated genes. Cancer Res 58: 5718\u20135724","journal-title":"Cancer Res"},{"key":"BF6601127_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1006\/bbrc.1998.8238","volume":"244","author":"P Henttu","year":"1998","unstructured":"Henttu P, Vihko P (1998) The protein kinase C activator, phorbol ester, elicits disparate functional responses in androgen-sensitive and androgen-independent human prostatic cancer cells. Biochem Biophyls Res Commun 244: 167\u2013171","journal-title":"Biochem Biophyls Res Commun"},{"key":"BF6601127_CR11","first-page":"314","volume":"57","author":"P Koivisto","year":"1997","unstructured":"Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T, Kallioniemi O-P (1997) Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res 57: 314\u2013319","journal-title":"Cancer Res"},{"key":"BF6601127_CR12","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/(SICI)1096-9896(199910)189:2<219::AID-PATH423>3.0.CO;2-F","volume":"189","author":"PA Koivisto","year":"1999","unstructured":"Koivisto PA, Helin HJ (1999) Androgen receptor gene amplification increases tissue PSA protein expression in hormone-refractory prostate carcinoma. J Pathol 189: 219\u2013223","journal-title":"J Pathol"},{"key":"BF6601127_CR13","doi-asserted-by":"publisher","first-page":"s34","DOI":"10.1038\/sj.bjc.6600373","volume":"86","author":"NS Krishna","year":"2002","unstructured":"Krishna NS, Edwards J, Underwood MA, Grigor KM, Bartlett JMS (2002) AP-1 as a mediator of androgen refractory prostate cancer. Br J Cancer 86: s34","journal-title":"Br J Cancer"},{"key":"BF6601127_CR14","doi-asserted-by":"publisher","first-page":"7200","DOI":"10.1073\/pnas.121173298","volume":"98","author":"HK Lin","year":"2001","unstructured":"Lin HK, Yeh S, Kang HY, Chang C (2001) Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor. Proc Nat Acad Sci USA 98: 7200\u20137205","journal-title":"Proc Nat Acad Sci USA"},{"key":"BF6601127_CR15","first-page":"1919","volume":"61","author":"A Latil","year":"2001","unstructured":"Latil A, Bieche I, Vidaud D, Lidereau R, Berthon P, Cussenot, Vidaud M (2001) Evaluation of androgen, estrogen (ER\u03b1 and ER\u03b2), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription\u2013polymerase chain reaction assays. Cancer Res 61: 1919\u20131926","journal-title":"Cancer Res"},{"key":"BF6601127_CR16","first-page":"3550","volume":"61","author":"MJ Linja","year":"2001","unstructured":"Linja MJ, Savinainen KJ, Saramaki OR, Tammela TL, Vessella RL, Visakorpi T (2001) Amplification and overexpression of androgen receptor gene in hormone-refractory prostate cancer. Cancer Res 61: 3550\u20133555","journal-title":"Cancer Res"},{"key":"BF6601127_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/(SICI)1097-0045(20000515)43:3<225::AID-PROS9>3.0.CO;2-7","volume":"43","author":"Y Miyoshi","year":"2000","unstructured":"Miyoshi Y, Uemura H, Fujinami K, Mikata K, Harada M, Kitamura H, Koizumi Y, Kubota Y (2000) Fluorescence in situ hybridization evaluation of c-myc and androgen receptor gene amplification and chromosomal anomalies in prostate cancer in Japanese patients. Prostate 43: 225\u2013232","journal-title":"Prostate"},{"key":"BF6601127_CR18","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S0090-4295(99)80323-9","volume":"49","author":"D Newling","year":"1997","unstructured":"Newling D, Fossa SD, Anderson L, Abrahamsson PA, Aso Y, Eisenberger MA, Khoury S, Kozlowski JS, Kelly K, Scher H, Hartley-Asp B (1997) Assessment of hormone refractory prostate cancer. Urology 49: 46\u201353","journal-title":"Urology"},{"key":"BF6601127_CR19","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1046\/j.1440-1827.2001.01226.x","volume":"51","author":"N Segawa","year":"2001","unstructured":"Segawa N, Mori I, Utsunomiya H, Nakamura M, Nakamura Y, Shan L, Kakudo K, Katsuoka Y (2001) Prognostic significance of neuroendocrine differentiation, proliferation activity and androgen receptor expression in prostate cancer. Pathol Int 51: 452\u2013459","journal-title":"Pathol Int"},{"key":"BF6601127_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/scbi.1997.0050","volume":"8","author":"J Trapman","year":"1997","unstructured":"Trapman J, Cleutjens KBJM (1997) Androgen-regulated gene expression in prostate cancer. Semin Cancer Biol 8: 29\u201336","journal-title":"Semin Cancer Biol"},{"key":"BF6601127_CR21","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/ng0495-401","volume":"9","author":"T Visakorpi","year":"1995","unstructured":"Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet 9: 401\u2013406","journal-title":"Nat Genet"},{"key":"BF6601127_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0303-7207(97)00168-8","volume":"134","author":"X Zhu","year":"1997","unstructured":"Zhu X, Liu JP (1997) Steroid-independent activation of androgen receptor in androgen-independent prostate cancer: a possible role for the MAP kinase signal transduction pathway? Mol Cell Endo 134: 9\u201314","journal-title":"Mol Cell Endo"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601127","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:51:22Z","timestamp":1684414282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7,29]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,8]]}},"alternative-id":["BF6601127"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601127","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7,29]]}}}